Sandoz is a global leader in generic and biosimilar medicines, committed to playing a leading role in driving access to medicines worldwide. Italy has significant footprint in the Sandoz European and global network, being a leading supplier of generic and biosimilar medicines for the Italian society.
The Head of Corporate Affairs is responsible for creating, coordinating and implementing the ‘shaping the external environment’ vision and strategy for Sandoz Italy and in close alignment with Global and Region Europe. A well defined Corporate Affairs plan should support all business activities covering our Italian activities. The plan should incorporate external and internal communication and PGA activities to engage with associates, media and external decision makers and stakeholders such as associations, patient groups and EU / ITA policy makers.
The role integrates a proactive communications plan for external stakeholders relevant to the organization to advocate for the objectives of the company as defined in the above mentioned master plan and in alignment with the broader global Sandoz Communications & Engagement strategy, so as to protect and promote a positive perception and reputation for Sandoz.
The role is also part of the Sandoz Emergency Management (SEM) team to support with managing the reputational aspect of any crisis situation.
Alignment with global communications and Europe Corporate Affairs team is success critical to have an impact in Italy.
The Head of Corporate Affairs Italy reports in line to the Head of Corporate Affairs Region Europe and dotted line to the Country Head of Sandoz Italy.
Develop, align and evolve a corporate affairs Master Plan for Italy, incorporating all Sandoz businesses and support the business growth. The plan should focus on federal policy makers and build on projects with high public visibility.
Languages
Experience and Skills
Sandoz compensation is determined by job level, qualifications, niche skills, experience, and location within company salary ranges. Fully proficient and highly effective employees can expect a starting salary around market median, with those new to the level or with less functional depth at the lower end of the range and those with sustained superior or niche skills towards the higher end of the range. Internal equity and external market data inform our range placement. Annual salary reviews consider performance outcomes, market alignment, and business needs.
Sandoz is the global leader in Biosimilar and Generic medicines, a segment of the healthcare industry that delivers 80% of the world’s medicines at 30% of the cost, touching the lives of more than 1 billion people across 100+ countries! While we are proud of our achievements, we have an ambition to do more so that everyone can achieve the basic human right of good health.
With investments in new development capabilities, production sites, new acquisitions, and partnerships, we have the opportunity to shape the future of Sandoz and help even more people gain access to low-cost, high-quality medicines, sustainably.
Our momentum is powered by an open, collaborative culture driven by our talented and ambitious colleagues, who, in return for applying their skills, experience an agile and collegiate environment with impactful careers, where diversity of thought is welcomed and where personal growth is supported!
Join us, help us make healthcare fairer and faster.
Affiliate Marketing, Communication Medium, Corporate Communication, Creativity, Curiosity, Employee Engagement, Internal Communications (Ic), Interviewing Skills, Marketing, Media Relations, Public Affairs, Social Media, Strategic Communications, W3

Sandoz is the global leader in generic and biosimilar medicines, with a growth strategy driven by its Purpose: pioneering access for patients.
More than 20,000 people of 100 nationalities work together to ensure 900 million patient treatments are provided by Sandoz annually, generating substantial global healthcare savings and an even larger social impact. Its leading portfolio of approximately 1,300 products addresses diseases from the common cold to cancer.
Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. Its history of breakthroughs includes Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the world’s first biosimilar in 2006. In 2024, Sandoz recorded net sales of USD 10.4 billion.
Read our community engagement guidelines: http://bit.ly/4ofoggc